Johnson Chemical Pharmaceutical Works Co Ltd Market Cap ($65.17 Million)
Market Cap & Net Worth: Johnson Chemical Pharmaceutical Works Co Ltd (4747)
Johnson Chemical Pharmaceutical Works Co Ltd market cap. Johnson Chemical Pharmaceutical Works Co Ltd (TWO:4747) has a market capitalization of $65.17 Million (NT$2.07 Billion) as of November 4, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #20667 globally and #1240 in its home market, demonstrating a -1.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Johnson Chemical Pharmaceutical Works Co Ltd's stock price NT$22.75 by its total outstanding shares 90922064 (90.92 Million). Also see how efficiently does Johnson Chemical Pharmaceutical Works Co generate cash for how efficiently the company converts equity into cash flow.
Johnson Chemical Pharmaceutical Works Co Ltd Market Cap History (2015–2026)
Johnson Chemical Pharmaceutical Works Co Ltd market cap history from 2015 to 2026. Data shows change from $76.00 Million to $65.17 Million (-0.98% CAGR). Check 4747 stock price for real-time trading data and today's change.
Johnson Chemical Pharmaceutical Works Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Johnson Chemical Pharmaceutical Works Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 4747 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.30x
Johnson Chemical Pharmaceutical Works Co Ltd's market cap is 0.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.17x
Johnson Chemical Pharmaceutical Works Co Ltd's market cap is 3.17 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $67.99 Million | $392.42 Million | $63.45 Million | 0.17x | 1.07x |
| 2017 | $76.68 Million | $394.61 Million | $60.01 Million | 0.19x | 1.28x |
| 2018 | $80.38 Million | $411.91 Million | $57.28 Million | 0.20x | 1.40x |
| 2019 | $84.28 Million | $425.34 Million | $64.47 Million | 0.20x | 1.31x |
| 2020 | $83.82 Million | $424.01 Million | $63.56 Million | 0.20x | 1.32x |
| 2021 | $83.07 Million | $411.49 Million | $49.10 Million | 0.20x | 1.69x |
| 2022 | $126.92 Million | $494.67 Million | $64.85 Million | 0.26x | 1.96x |
| 2023 | $234.89 Million | $606.71 Million | $79.70 Million | 0.39x | 2.95x |
| 2024 | $204.81 Million | $611.41 Million | $84.12 Million | 0.33x | 2.43x |
| 2025 | $169.58 Million | $569.77 Million | $53.51 Million | 0.30x | 3.17x |
Competitor Companies of 4747 by Market Capitalization
Companies near Johnson Chemical Pharmaceutical Works Co Ltd in the global market cap rankings as of November 4, 2026. Also see Johnson Chemical Pharmaceutical Works Co (4747) total assets for a full breakdown of the balance sheet.
Key companies related to Johnson Chemical Pharmaceutical Works Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Johnson Chemical Pharmaceutical Works Co Ltd (2015–2026)
Market capitalization of Johnson Chemical Pharmaceutical Works Co Ltd from 2015 to today. Between 2015 and today, Johnson Chemical Pharmaceutical Works Co Ltd's market cap moved from $76.00 Million to $ 65.17 Million, with a yearly change of -0.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$65.17 Million | -61.57% |
| 2025 | NT$169.58 Million | -17.20% |
| 2024 | NT$204.81 Million | -12.80% |
| 2023 | NT$234.89 Million | +85.07% |
| 2022 | NT$126.92 Million | +52.79% |
| 2021 | NT$83.07 Million | -0.90% |
| 2020 | NT$83.82 Million | -0.54% |
| 2019 | NT$84.28 Million | +4.85% |
| 2018 | NT$80.38 Million | +4.83% |
| 2017 | NT$76.68 Million | +12.78% |
| 2016 | NT$67.99 Million | -10.55% |
| 2015 | NT$76.00 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Johnson Chemical Pharmaceutical Works Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $65.17 Million USD |
| MoneyControl | $65.17 Million USD |
| MarketWatch | $65.17 Million USD |
| marketcap.company | $65.17 Million USD |
| Reuters | $65.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more